Teresa Pacifico

Rome, 00133, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

From Gut Homeostasis to Colorectal Cancer: Spatial and Temporal Reprogramming of Microbial Inosine Signaling.

From Gut Homeostasis to Colorectal Cancer: Spatial and Temporal Reprogramming of Microbial Inosine Signaling.

Journal: Biomedicines

Published: March 26, 2026

Gut Microbiota in Lipodystrophies and Obesity: A Common Signature?

Gut Microbiota in Lipodystrophies and Obesity: A Common Signature?

Journal: Microorganisms

Published: November 12, 2025

Targeting Cancer Cell Energy Metabolism in Colorectal Cancer: Opportunities and Challenges from Drug Repositioning.

Targeting Cancer Cell Energy Metabolism in Colorectal Cancer: Opportunities and Challenges from Drug Repositioning.

Journal: Cells

Published: October 19, 2025

Rafoxanide disrupts mitochondrial homeostasis through VDAC1 modulation in colorectal cancer cells.

Rafoxanide disrupts mitochondrial homeostasis through VDAC1 modulation in colorectal cancer cells.

Journal: Cell death discovery

Published: October 07, 2025

Intestinal epithelial Smad7 drives purine metabolic dysregulation and ileal inflammation.

Intestinal epithelial Smad7 drives purine metabolic dysregulation and ileal inflammation.

Journal: Journal of biomedical science

Published: September 01, 2025

Repurposing Rafoxanide: From Parasite Killer to Cancer Fighter.

Repurposing Rafoxanide: From Parasite Killer to Cancer Fighter.

Journal: Biomedicines

Published: June 09, 2025

Targeting hepcidin in colorectal cancer triggers a TNF-dependent-gasdermin E-driven immunogenic cell death response.

Targeting hepcidin in colorectal cancer triggers a TNF-dependent-gasdermin E-driven immunogenic cell death response.

Journal: Experimental hematology & oncology

Published: June 26, 2024

Rafoxanide negatively modulates STAT3 and NF-κB activity and inflammation-associated colon tumorigenesis.

Rafoxanide negatively modulates STAT3 and NF-κB activity and inflammation-associated colon tumorigenesis.

Journal: Cancer science

Published: March 28, 2024

Bromodomain-containing 4 is a positive regulator of the inflammatory cytokine response in the gut.

Bromodomain-containing 4 is a positive regulator of the inflammatory cytokine response in the gut.

Journal: Journal of Crohn's & colitis

Published: March 15, 2024

TRAIL-Sensitizing Effects of Flavonoids in Cancer.

TRAIL-Sensitizing Effects of Flavonoids in Cancer.

Journal: International journal of molecular sciences

Published: October 13, 2023

Impact of Western Diet and Ultra-Processed Food on the Intestinal Mucus Barrier.

Impact of Western Diet and Ultra-Processed Food on the Intestinal Mucus Barrier.

Journal: Biomedicines

Published: April 28, 2023

Anthelmintic Drugs as Emerging Immune Modulators in Cancer.

Anthelmintic Drugs as Emerging Immune Modulators in Cancer.

Journal: International journal of molecular sciences

Published: March 02, 2023

Showing 1-12 of 16

Last Updated: 09/26/2026